MAIA Biotechnology | Investor Presentation Deck | 39 slides · page 27 of 39
The table compares an existing standard of care (Zepzelca) against the company's planned trial (THIO-102).
Pitch deck · comparison_table · compare_peers · balanced density
Slide locked Sign in to view
Slide schematic 4/4
list 1/1 paragraph 1/1 table 1/1 title 1/1
Components 4
bullet paragraph data headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1